Daiwa Securities Group Inc. Sells 200 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Daiwa Securities Group Inc. decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 10.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,800 shares of the company’s stock after selling 200 shares during the quarter. Daiwa Securities Group Inc.’s holdings in HealthEquity were worth $147,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of HQY. Mackenzie Financial Corp lifted its holdings in shares of HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after acquiring an additional 325,906 shares during the period. Generate Investment Management Ltd acquired a new position in HealthEquity during the 2nd quarter worth about $24,184,000. Vaughan Nelson Investment Management L.P. raised its holdings in HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares during the last quarter. Thrivent Financial for Lutherans lifted its holdings in HealthEquity by 924.2% in the second quarter. Thrivent Financial for Lutherans now owns 220,220 shares of the company’s stock valued at $18,983,000 after buying an additional 198,718 shares during the period. Finally, Overbrook Management Corp bought a new stake in HealthEquity during the second quarter valued at $12,284,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ HQY opened at $101.54 on Monday. The company has a 50-day simple moving average of $90.16 and a 200 day simple moving average of $82.81. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $105.82. The company has a market capitalization of $8.87 billion, a PE ratio of 84.62, a price-to-earnings-growth ratio of 1.59 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.16. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. On average, research analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on HQY shares. Bank of America boosted their price objective on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. BTIG Research increased their price target on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 price objective for the company. Barrington Research reiterated an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a research report on Friday, September 20th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $107.23.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now directly owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the transaction, the director now directly owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. This represents a 20.54 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,536 shares of company stock valued at $884,517. Company insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.